Multifunctional PLGA Nanoparticles: pH-Triggered Drug Release for Pancreatic Ductal Adenocarcinoma
- 28 May 2026
- journal article
- Published by Springer Nature in BioNanoScience
- Vol. 16 (6)
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology-Science and Engineering Research Board (DST-SERB) India (EEQ/2022/000419)
This publication has 35 references indexed in Scilit:
- Understanding cytotoxicity induction by plumbagin in pancreatic ductal adenocarcinoma using network pharmacology, bioinformatic and in-vitro studyCytotechnology, 2026
- PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancerCell Reports, 2024
- Nature meets technology: Harnessing nanotechnology to unleash the power of phytochemicalsClinical Traditional Medicine and Pharmacology, 2024
- Nanomaterial surface modification toolkit: Principles, components, recipes, and applicationsAdvances in Colloid and Interface Science, 2023
- Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic wayPhytochemistry Reviews, 2023
- Microfluidics-based PLGA nanoparticles of ratiometric multidrug: From encapsulation and release rates to cytotoxicity in human lens epithelial cellsHeliyon, 2023
- Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapyBiomedicine & Pharmacotherapy, 2023
- A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapyCritical Reviews in Oncology/Hematology, 2023
- Biodegradable nanoparticulate co-delivery of flavonoid and doxorubicin: Mechanistic exploration and evaluation of anticancer effect in vitro and in vivoBiomaterials and Biosystems, 2021
- Unfolding antifungals: as a new foe to pancreatic ductal adenocarcinoma—a mini-reviewMolecular Biology Reports, 2021